EE02948B1 - Metüleenbisfosfoonhappe derivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon - Google Patents

Metüleenbisfosfoonhappe derivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon

Info

Publication number
EE02948B1
EE02948B1 EE9400229A EE9400229A EE02948B1 EE 02948 B1 EE02948 B1 EE 02948B1 EE 9400229 A EE9400229 A EE 9400229A EE 9400229 A EE9400229 A EE 9400229A EE 02948 B1 EE02948 B1 EE 02948B1
Authority
EE
Estonia
Prior art keywords
opt
unsatd
substd
branched
preparation
Prior art date
Application number
EE9400229A
Other languages
English (en)
Inventor
Nikander Hannu
Heikkil�-Hoikka Marjaana
Pohjala Esko
Hanhij�rvi Hannu
Laur�n Leena
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of EE02948B1 publication Critical patent/EE02948B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5537—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom the heteroring containing the structure -C(=O)-N-C(=O)- (both carbon atoms belong to the heteroring)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Detergent Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
EE9400229A 1990-12-20 1994-11-14 Metüleenbisfosfoonhappe derivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon EE02948B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI906294A FI89364C (fi) 1990-12-20 1990-12-20 Foerfarande foer framstaellning av nya, farmakologiskt anvaendbara metylenbisfosfonsyraderivat

Publications (1)

Publication Number Publication Date
EE02948B1 true EE02948B1 (et) 1996-12-16

Family

ID=8531619

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400229A EE02948B1 (et) 1990-12-20 1994-11-14 Metüleenbisfosfoonhappe derivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon

Country Status (25)

Country Link
US (1) US5438048A (et)
EP (1) EP0563096B1 (et)
JP (1) JP3347324B2 (et)
KR (1) KR100233986B1 (et)
CN (1) CN1030609C (et)
AT (1) ATE192451T1 (et)
AU (1) AU665342B2 (et)
CA (1) CA2098732C (et)
CZ (1) CZ287453B6 (et)
DE (1) DE69132163T2 (et)
DK (1) DK0563096T3 (et)
EE (1) EE02948B1 (et)
ES (1) ES2147183T3 (et)
FI (1) FI89364C (et)
HU (1) HUT64546A (et)
IE (1) IE914388A1 (et)
IL (1) IL100338A (et)
NO (1) NO301590B1 (et)
NZ (1) NZ241041A (et)
PL (1) PL169772B1 (et)
RU (1) RU2079504C1 (et)
SK (1) SK281788B6 (et)
TW (1) TW203054B (et)
WO (1) WO1992011267A1 (et)
ZA (1) ZA9110009B (et)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157027A (en) * 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
US5591730A (en) * 1993-10-12 1997-01-07 The Regents Of The University Of California Inhibition of urinary calculi growth
FI104901B (fi) 1997-10-20 2000-04-28 Leiras Oy Uudet metyleenibisfosfonihappojohdannaiset
AU6991400A (en) * 1999-08-03 2001-02-19 Amersham Plc Radiolabelled bisphosphonates and method
PL196485B1 (pl) * 2000-05-11 2008-01-31 Inst Farmaceutyczny Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
CA2427301C (en) * 2000-10-27 2009-12-22 Schering Oy Method for the preparation of a pharmaceutical composition, and its use
CA2431515C (en) * 2001-01-23 2008-01-22 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof
JP2004528340A (ja) * 2001-05-02 2004-09-16 ノバルティス アクチエンゲゼルシャフト ビスホスホネートの医薬的使用
FR2837490B1 (fr) * 2002-03-21 2009-04-17 Univ Paris 13 Nouveaux derives de bisphosphonates, leurs preparations et utilisations
CA2451881A1 (fr) * 2001-07-16 2003-01-30 Universite Paris 13 Nouveaux derives de bisphosphonates, leurs preparations et utilisations
US20030036537A1 (en) * 2001-07-16 2003-02-20 Marc Lecouvey Bisphosphonate derivatives, their preparations and uses
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080286359A1 (en) * 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en) * 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2010035664A1 (ja) * 2008-09-24 2010-04-01 田辺三菱製薬株式会社 ビスホスホン酸誘導体の製法
CN107011380A (zh) * 2016-01-28 2017-08-04 臧伟 一种二膦酸衍生物及含二膦酸衍生物的组合物治疗骨折的应用
TWI730039B (zh) * 2016-01-29 2021-06-11 日商富士藥品股份有限公司 新穎雙膦酸化合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303139A (en) * 1962-01-27 1967-02-07 Henkel & Cie Gmbh Aminophosphonic acids and their derivatives as complex formers for metal ions
DE1202441B (de) * 1963-03-02 1965-10-07 Therachemie Chem Therapeut Mittel zur Verminderung der Schaedigung von Haaren beim Bleichen und Faerben
DE1617118C3 (de) * 1966-08-26 1975-04-03 Henkel & Cie Gmbh, 4000 Duesseldorf Verfahren zur Reinigung von etikettierten starren Gegenständen
US3962318A (en) * 1970-04-13 1976-06-08 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US3957858A (en) * 1970-04-13 1976-05-18 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
CH555894A (fr) * 1972-08-10 1974-11-15 Oxy Metal Industries Corp Utilisation de derives organophosphores dans les bains sulfitiques pour l'electrodeposition de l'or et des alliages d'or.
US4113861A (en) * 1977-05-02 1978-09-12 The Procter & Gamble Company Phosphonate pharmaceutical composition
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
US4634691A (en) * 1980-10-07 1987-01-06 The Procter & Gamble Company Method for inhibiting tumor metastasis
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
US4818774A (en) * 1986-03-10 1989-04-04 Occidental Chemical Corporation Organophosphorus compounds
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
EP0563096A1 (en) 1993-10-06
CA2098732A1 (en) 1992-06-21
FI89364B (fi) 1993-06-15
KR100233986B1 (ko) 1999-12-15
AU9074991A (en) 1992-07-22
NO301590B1 (no) 1997-11-17
FI89364C (fi) 1993-09-27
JP3347324B2 (ja) 2002-11-20
ZA9110009B (en) 1992-09-30
FI906294A (fi) 1992-06-21
EP0563096B1 (en) 2000-05-03
NO932254L (no) 1993-08-19
CN1030609C (zh) 1996-01-03
IL100338A (en) 1998-01-04
NZ241041A (en) 1994-09-27
RU2079504C1 (ru) 1997-05-20
CZ287453B6 (cs) 2000-11-15
ES2147183T3 (es) 2000-09-01
PL169772B1 (pl) 1996-08-30
HUT64546A (en) 1994-01-28
KR930703334A (ko) 1993-11-29
AU665342B2 (en) 1996-01-04
WO1992011267A1 (en) 1992-07-09
CN1062532A (zh) 1992-07-08
DK0563096T3 (da) 2000-09-25
ATE192451T1 (de) 2000-05-15
IL100338A0 (en) 1992-09-06
NO932254D0 (no) 1993-06-18
SK62993A3 (en) 1993-12-08
US5438048A (en) 1995-08-01
JPH06504045A (ja) 1994-05-12
CA2098732C (en) 2002-03-05
FI906294A0 (fi) 1990-12-20
HU9301779D0 (en) 1993-09-28
SK281788B6 (sk) 2001-07-10
DE69132163T2 (de) 2001-01-11
IE914388A1 (en) 1992-07-01
CZ119893A3 (en) 1994-02-16
DE69132163D1 (de) 2000-06-08
TW203054B (et) 1993-04-01

Similar Documents

Publication Publication Date Title
EE02948B1 (et) Metüleenbisfosfoonhappe derivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon
EE02949B1 (et) Metüleenbisfosfoonhappe derivaadid, meetod nende valmistamiseks ja farmatsutiline kompositsioon
ES2014220B3 (es) Nuevos derivados de acido difosfonico, procedimiento para su preparacion y medicamentos que contienen estos compuestos.
ATE4903T1 (de) 1-, 6- und 2-substituierte 1-carba-2-penem-3carbons[ure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES2123654T3 (es) Carbapenems que contienen un grupo fenilo substituido con carboxi, procesos para su preparacion, productos intermedios y uso como antibioticos.
FI871585A0 (fi) Menetelmä kiinteän valmisteen valmistamiseksi, josta aktiivista yhdistettä vapautuu pidennetyn ajanjakson ajan
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
IL104090A (en) Phosphonosuccinic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing these compounds
AR007960A1 (es) Nuevos derivados de imino, procedimiento para su preparacion, preparado farmaceutico que los contiene y su utilizacion
ES2109988T3 (es) Derivados cefalosporinicos.
SE7904543L (sv) Nya joniska bensen-polyjodidderivat for anvendning som kontrastmedel vid rontgenbehandling
DE3262357D1 (en) ((indol-3-yl)-3-amino-2 propionyloxy)-2-acetic-acid derivatives, process for their preparation and pharmaceutical preparations containing them
FI950259A0 (fi) Uudet, asykliset, amidiiniryhmiä sisältävät difosfonihappojohdannaiset, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
ATE29251T1 (de) Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
SE8204791L (sv) Sett att framstella alkoxivinkaminsyraestrar och alkoxiapovinkaminsyraestrar
JPS54144333A (en) Tetrapeptide derivative

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20041114